CN112869164A - Preparation method of broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) - Google Patents
Preparation method of broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) Download PDFInfo
- Publication number
- CN112869164A CN112869164A CN202110229958.8A CN202110229958A CN112869164A CN 112869164 A CN112869164 A CN 112869164A CN 202110229958 A CN202110229958 A CN 202110229958A CN 112869164 A CN112869164 A CN 112869164A
- Authority
- CN
- China
- Prior art keywords
- nmn
- enzymolysis
- fermentation
- broccoli
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 title claims abstract description 53
- 235000017647 Brassica oleracea var italica Nutrition 0.000 title claims abstract description 53
- 240000003259 Brassica oleracea var. botrytis Species 0.000 title claims abstract description 53
- 239000000284 extract Substances 0.000 title claims abstract description 46
- FZAQROFXYZPAKI-UHFFFAOYSA-N anthracene-2-sulfonyl chloride Chemical compound C1=CC=CC2=CC3=CC(S(=O)(=O)Cl)=CC=C3C=C21 FZAQROFXYZPAKI-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000000855 fermentation Methods 0.000 claims abstract description 49
- 230000004151 fermentation Effects 0.000 claims abstract description 49
- 230000001954 sterilising effect Effects 0.000 claims abstract description 35
- 238000003756 stirring Methods 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 31
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 24
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 20
- 108090000790 Enzymes Proteins 0.000 claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 claims abstract description 15
- 229940088598 enzyme Drugs 0.000 claims abstract description 15
- 108010059892 Cellulase Proteins 0.000 claims abstract description 14
- 108010059820 Polygalacturonase Proteins 0.000 claims abstract description 14
- 229940106157 cellulase Drugs 0.000 claims abstract description 14
- 108010093305 exopolygalacturonase Proteins 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 12
- 239000008103 glucose Substances 0.000 claims abstract description 12
- 241000208340 Araliaceae Species 0.000 claims abstract description 10
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 10
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 10
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 7
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims abstract description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 6
- 235000001727 glucose Nutrition 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 238000002386 leaching Methods 0.000 claims abstract description 6
- 238000004537 pulping Methods 0.000 claims abstract description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 19
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 19
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 14
- 238000000926 separation method Methods 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 11
- 230000003712 anti-aging effect Effects 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 230000002779 inactivation Effects 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000010802 sludge Substances 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 7
- 235000005152 nicotinamide Nutrition 0.000 claims description 7
- 239000011570 nicotinamide Substances 0.000 claims description 7
- 229960003966 nicotinamide Drugs 0.000 claims description 7
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 7
- 235000013376 functional food Nutrition 0.000 claims description 6
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 6
- 230000004913 activation Effects 0.000 claims description 5
- 238000009630 liquid culture Methods 0.000 claims description 5
- 238000010907 mechanical stirring Methods 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 230000009849 deactivation Effects 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 239000007858 starting material Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 abstract description 13
- 230000000415 inactivating effect Effects 0.000 abstract description 3
- 238000005086 pumping Methods 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 description 40
- 239000000243 solution Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 5
- 238000006555 catalytic reaction Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- 101001076781 Fructilactobacillus sanfranciscensis (strain ATCC 27651 / DSM 20451 / JCM 5668 / CCUG 30143 / KCTC 3205 / NCIMB 702811 / NRRL B-3934 / L-12) Ribose-5-phosphate isomerase A Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 102000046755 Ribokinases Human genes 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229950006238 nadide Drugs 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000010855 food raising agent Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 108010025076 Holoenzymes Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- JLEBZPBDRKPWTD-TURQNECASA-O N-ribosylnicotinamide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)=C1 JLEBZPBDRKPWTD-TURQNECASA-O 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 1
- 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 1
- 108010024137 Nicotinamide-Nucleotide Adenylyltransferase Proteins 0.000 description 1
- 102000015597 Nicotinamide-nucleotide adenylyltransferase Human genes 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a preparation method of a broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN), which comprises the following steps: the method comprises the following steps: pre-treating, namely, respectively selecting, cleaning, carrying out ozone sterilization, leaching, draining and pulping on the broccoli, pumping the broccoli into a sterile fermentation tank through a thick pulp pump, adding a red date extraction concentrated solution (containing adenosine cyclophosphate), a ginseng extraction concentrated solution (containing ATP) and water, stirring and mixing uniformly, and carrying out the second step: performing enzymolysis before fermentation, namely adding pectinase and cellulase into the mixed pulp obtained by the pretreatment in the step one to perform enzymolysis, and performing the step three: and (3) fermentation, namely adding glucose, nicotinamide, magnesium sulfate and dipotassium hydrogen phosphate into the mixed liquor obtained by the second enzymolysis, stirring for dissolving, heating, inactivating enzymes and sterilizing, and performing the fourth step: and (3) post-treatment, namely, the fermentation liquor obtained by fermenting in the step three is greatly reduced in environmental pollution compared with the prior art (CN110559224A, broccoli extract contains about 1.4% w/w of NMN) and compared with the traditional method.
Description
Technical Field
The invention relates to the technical field of functional food preparation by a fermentation method, in particular to a preparation method of a broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN).
Background
Nicotinamide Mononucleotide (NMN) is an endogenous substance in the human body and is produced by nicotinamide under the catalysis of nicotinamide phosphoribosyltransferase, and then NMN produces NAD + (nicotinamide adenine dinucleotide) under the catalysis of nicotinamide mononucleotide adenylyltransferase. The physiological effects of NMN in humans are all accomplished by conversion to NAD +. The existing scientific research shows that NMN can improve ischemic brain injury and Alzheimer's disease, has therapeutic effect on Parkinson's disease, degenerative disease ] and obesity, and can also relieve myocardial ischemia reperfusion injury, cerebral hemorrhage and cerebral infarction hemorrhage injury, and the like; the most popular recent research is the development and application of NMN in the aspects of anti-aging, medicine and health care products. The American scientist David Sinclair doctor has proved that NMN has the effect of reversing physiological aging in mice, and Japan pioneers the main beating product in 2016, but the content of beta-nicotinamide mononucleotide is only 3000mg (eating 10 days) but the price is close to 7000 yuan. The poor cost performance of the japanese beta-nicotinamide mononucleotide product limits the popularization of the revolutionary anti-aging substance, and almost falls into rich privilege. In 2018, a dietary supplement product Reinvigoror (China: Revitto) based on research results of Harvard medical college was issued by Herbalmax (American biotechnology company), the main component of the product is NMN, and the price of the drug-grade NMN is successfully reduced by more than 90% by Herbalmax through a biological enzyme catalysis technology (the price of basic editions such as Jingdong, Tecatus, suning and the like is not more than 2000 yuan), so that the administration cost of the NMN enters the bearing range of general high-income groups. In 2018, NMN proved by experiment of Greenwich aging biology center of Harvard university can prolong the life of mammals by more than 30%. For this reason, the main discoverer of NMN anti-aging efficacy-professor of harvard medical college, professor of paul, F, gren bioscience, the principal David Sinclair, was also rated by the time magazine as "100 people most influential worldwide". On 11 months 2 in 2020, a new result was developed by the professor David Sinclair at the medical college of harvard university and the professor Lindsay Wu at the university of new south welsh by the lead team: NMN can reverse oocyte senescence, thereby restoring fertility to women during reproductive senescence. In addition to pharmaceutical and nutraceutical products containing NMN as an active ingredient, NMN is also found in emulsions in natural foods such as vegetables, fruits, meats, and mammals. According to the FDA equivalent principle, one 70kg adult should supplement 600mg of NMN every day, and one adult needs to eat 54-240 kg of broccoli when supplementing the same amount of NMN, so that the efficiency of directly eating the broccoli source supplement is low, and the effect can be quickly achieved by preparing a broccoli extract (containing more than 5.0% of NMN w/w) with high NMN content through a fermentation method.
Patent CN110559224A discloses an extract of broccoli, its preparation method and application. Adding an extraction solvent into broccoli powder, performing ultrasonic-assisted extraction for 60-90 min, collecting an extracting solution, cooling, centrifuging, performing reduced-pressure filtration and filter membrane ultrafiltration, and collecting a filtrate; C) and (4) carrying out vacuum freeze drying on the collected filtrate to obtain the broccoli extract. The content of nicotinamide mononucleotide in the broccoli extract prepared by the method is only 13.724 mug/mg (about equivalent to 1.4% w/w).
At present, other production processes reported in China adopt a chemical synthesis method and an enzymatic method, wherein the chemical synthesis method uses ribose nicotinate as a raw material and uses phosphorus oxychloride for phosphorylation to obtain NMN (reference: CHEM. COMMON.1999, 729-730), the yield is low, the product purity is poor, a large amount of organic solvent is used, the environmental damage is serious, and the phosphorus oxychloride is a relatively dangerous reagent. A holoenzyme process (CN201611245619) uses nicotinamide ribose as a substrate, and reacts in the presence of phosphate donors such as ATP and under the catalysis of nicotinamide ribokinase or recombinant cells containing nicotinamide ribokinase to generate beta-nicotinamide mononucleotide. The nicotinamide ribokinase used is from Saccharomyces cerevisiae.
However, in the two existing methods, a large amount of organic solvents and acid and alkali are used in the actual production process, so that the environment is greatly polluted.
Disclosure of Invention
1. Technical problem to be solved
The invention aims to solve the problem that a large amount of organic solvents and acid and alkali are used in the actual production process in the prior art, which causes great pollution to the environment, and provides a preparation method of a broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN).
2. Technical scheme
In order to achieve the purpose, the invention adopts the following technical scheme:
a method for preparing broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) comprises the following steps:
the method comprises the following steps: pre-treating, selecting, cleaning, sterilizing with ozone, leaching, pulping, adding into sterile fermentation tank with thick pulp pump, adding concentrated extractive solution of fructus Jujubae (containing adenosine cyclophosphate), concentrated extractive solution of Ginseng radix (containing ATP), and water, stirring, and mixing.
Step two: and (3) performing enzymolysis before fermentation, namely adding pectinase and cellulase into the mixed pulp obtained by the pretreatment in the step one to perform enzymolysis, wherein the enzymolysis temperature is 40-55 ℃, the enzymolysis pH is 3.4-6.5, and the enzymolysis time is 2-8 h.
Step three: and (3) fermenting, namely adding glucose, nicotinamide, magnesium sulfate and dipotassium hydrogen phosphate into the mixed liquor obtained in the second enzymolysis step respectively, stirring for dissolving, heating, carrying out enzyme deactivation and sterilization, cooling the mixed liquor to 20-32 ℃, inoculating a starter saccharomyces cerevisiae with the inoculation amount of 0.05-0.1%, maintaining the temperature at 20-32 ℃, fermenting for 3-7 days, intermittently stirring in the fermentation process, stirring for 20-30 minutes every 12 hours, wherein the stirring mode can be mechanical stirring, and can also be stirring by introducing sterile compressed air.
Step four: performing post-treatment, namely sterilizing, cooling, performing centrifugal separation on the fermentation liquor obtained in the third step to collect filtrate, concentrating the filtrate at low temperature under reduced pressure until the relative density of the extract is 1.01-1.05, and performing vacuum freeze drying to obtain the high-NMN-content broccoli extract, wherein the NMN content can reach more than 5.0% (w/w), and the extract can be used for anti-aging functional food; wherein the sterilization temperature is controlled at 60-90 deg.C, preferably 75-85 deg.C, and the sterilization time is 10-40 min, preferably 20-30 min; wherein the concentration temperature is 30-50 deg.C, preferably 35-45 deg.C, and vacuum degree is below 80 pa.
Preferably, in the step one, 600 parts of the broccoli, 300 parts of the red date extraction concentrated solution (containing adenosine cyclophosphate), 300 parts of the ginseng extraction concentrated solution (containing ATP) and 500 parts of water.
Preferably, the enzymolysis temperature in the second step is most preferably 48-52 ℃.
Preferably, the enzymolysis in the second step is most preferably pH 4.0-5.0.
Preferably, the enzymolysis time in the second step is preferably 4-5 h.
Preferably, the addition amount of the pectinase in the second step is 0.01-0.07%; wherein the addition amount of cellulase (1 ten thousand u/g) is 0.05-0.15%.
Preferably, the addition amount of the pectinase in the second step is preferably 0.03-0.05%.
Preferably, the addition amount of the cellulase (1 ten thousand u/g) in the second step is preferably 0.1-0.12%.
Preferably, the fermentation strain obtained in the third step is obtained by separating and screening fresh broccoli, is used as an original strain, and is subjected to activation (slant culture), amplification culture (liquid culture) and amplification culture in a Karschner jar, fermentation broth is subjected to centrifugal separation after fermentation is finished to obtain saccharomyces cerevisiae bacterial sludge, and the saccharomyces cerevisiae bacterial sludge is inoculated to the broccoli enzymolysis mixed liquor for fermentation; or directly adding the yeast liquid in the Kaschin tank into the blue flower enzymolysis mixed liquid for fermentation without centrifugal separation.
Preferably, the three steps comprise 1-8% of glucose, 0.1-1.0% of nicotinamide, 0.01-0.03% of magnesium sulfate and 0.2-0.3% of dipotassium phosphate, wherein the enzyme inactivation and sterilization temperature is controlled at 60-90 ℃, preferably 75-85 ℃, and the enzyme inactivation and sterilization time is 10-40 minutes, preferably 20-30 minutes.
3. Advantageous effects
Compared with the prior art, the invention has the advantages that:
in the invention, the product with high NMN content (containing more than 5.0% of NMN w/w) is produced at lower cost, compared with the prior art (CN110559224A, the broccoli extract contains about 1.4% of NMN w/w), and the environmental pollution is greatly reduced compared with the traditional method.
Drawings
FIG. 1 is a sample map of a preparation method of a broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to example 3 of the present invention;
FIG. 2 is a map of a control sample in example 3 of a method for preparing a broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments.
Example 1:
a method for preparing broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) comprises the following steps:
the method comprises the following steps: pre-treating, selecting, cleaning, sterilizing with ozone, leaching, pulping, adding into sterile fermentation tank with thick pulp pump, adding concentrated extractive solution of fructus Jujubae (containing adenosine cyclophosphate), concentrated extractive solution of Ginseng radix (containing ATP), and water, stirring, and mixing.
Step two: and (3) performing enzymolysis before fermentation, namely adding pectinase and cellulase into the mixed pulp obtained by the pretreatment in the step one to perform enzymolysis, wherein the enzymolysis temperature is 40-55 ℃, the enzymolysis pH is 3.4-6.5, and the enzymolysis time is 2-8 h.
Step three: and (3) fermenting, namely adding glucose, nicotinamide, magnesium sulfate and dipotassium hydrogen phosphate into the mixed liquor obtained in the second enzymolysis step respectively, stirring for dissolving, heating, carrying out enzyme deactivation and sterilization, cooling the mixed liquor to 20-32 ℃, inoculating a starter saccharomyces cerevisiae with the inoculation amount of 0.05-0.1%, maintaining the temperature at 20-32 ℃, fermenting for 3-7 days, intermittently stirring in the fermentation process, stirring for 20-30 minutes every 12 hours, wherein the stirring mode can be mechanical stirring, and can also be stirring by introducing sterile compressed air.
Step four: performing post-treatment, namely sterilizing, cooling, performing centrifugal separation on the fermentation liquor obtained in the third step to collect filtrate, concentrating the filtrate at low temperature under reduced pressure until the relative density of the extract is 1.01-1.05, and performing vacuum freeze drying to obtain the high-NMN-content broccoli extract, wherein the NMN content can reach more than 5.0% (w/w), and the extract can be used for anti-aging functional food; wherein the sterilization temperature is controlled at 60-90 deg.C, preferably 75-85 deg.C, and the sterilization time is 10-40 min, preferably 20-30 min; wherein the concentration temperature is 30-50 deg.C, preferably 35-45 deg.C, and vacuum degree is below 80 pa.
Example 2:
a method for preparing broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) comprises the following steps:
the method comprises the following steps: the method comprises the following steps of pretreatment, namely sorting, cleaning, carrying out ozone sterilization, leaching, draining and pulping the broccoli respectively, pumping the broccoli into a sterile fermentation tank by a thick slurry pump, adding 600 parts of red date extraction concentrated solution (containing adenosine cyclophosphate), 300 parts of ginseng extraction concentrated solution (containing ATP) and water, stirring and mixing uniformly, wherein in the step one, 300 parts of broccoli, 300 parts of red date extraction concentrated solution (containing adenosine cyclophosphate), 300 parts of ginseng extraction concentrated solution (containing ATP) and 500 parts of water are mixed.
Step two: performing enzymolysis before fermentation, namely adding pectinase and cellulase into the mixed pulp obtained by the pretreatment in the first step for enzymolysis, wherein the enzymolysis temperature is 40-55 ℃, the enzymolysis pH is 3.4-6.5, and the enzymolysis time is 2-8 h, the enzymolysis temperature in the second step is most preferably 48-52 ℃, the enzymolysis pH in the second step is most preferably 4.0-5.0, the enzymolysis time in the second step is preferably 4-5h, and the addition amount of the pectinase in the second step is 0.01-0.07%; wherein the addition amount of cellulase (1 wu/g) is 0.05-0.15%, the addition amount of pectinase in the second step is preferably 0.03-0.05%, and the addition amount of cellulase (1 wu/g) in the second step is preferably 0.1-0.12%.
Step three: fermenting, adding glucose, nicotinamide, magnesium sulfate and dipotassium hydrogen phosphate into the mixed solution obtained by the second enzymolysis, stirring for dissolving, heating, inactivating enzyme and sterilizing, cooling the mixed solution to 20-32 ℃, inoculating a leavening agent saccharomyces cerevisiae with the inoculum size of 0.05-0.1%, maintaining the temperature at 20-32 ℃, fermenting for 3-7 days, intermittently stirring in the fermentation process, stirring for 20-30 minutes every 12 hours, wherein the stirring mode can be mechanical stirring or stirring by introducing sterile compressed air, the fermentation strain obtained by separating and screening the fresh broccoli is used as an original strain, and is subjected to activation (slant culture), expanding culture (liquid culture) and Karschner jar amplification culture, fermentation broth is subjected to centrifugal separation after fermentation is finished to obtain saccharomyces cerevisiae bacterial sludge, and the saccharomyces cerevisiae bacterial sludge is inoculated to the broccoli enzymolysis mixed liquor for fermentation; or directly adding yeast liquid in a Kaschin tank into the blue flower enzymolysis mixed liquid for fermentation without centrifugal separation, wherein in the step three, the glucose is 1-8%, the nicotinamide is 0.1-1.0%, the magnesium sulfate is 0.01-0.03%, and the dipotassium hydrogen phosphate is 0.2-0.3%, wherein the enzyme inactivation and sterilization temperature is controlled at 60-90 ℃, preferably 75-85 ℃, and the enzyme inactivation and sterilization time is 10-40 minutes, preferably 20-30 minutes.
Step four: performing post-treatment, namely sterilizing, cooling, performing centrifugal separation on the fermentation liquor obtained in the third step to collect filtrate, concentrating the filtrate at low temperature under reduced pressure until the relative density of the extract is 1.01-1.05, and performing vacuum freeze drying to obtain the high-NMN-content broccoli extract, wherein the NMN content can reach more than 5.0% (w/w), and the extract can be used for anti-aging functional food; wherein the sterilization temperature is controlled at 60-90 deg.C, preferably 75-85 deg.C, and the sterilization time is 10-40 min, preferably 20-30 min; wherein the concentration temperature is 30-50 deg.C, preferably 35-45 deg.C, and vacuum degree is below 80 pa.
Example 3:
referring to fig. 1-2, a method for preparing a broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) comprises the following steps:
the method comprises the following steps: the method comprises the following steps of pretreatment, namely sorting, cleaning, carrying out ozone sterilization, leaching, draining and pulping the broccoli respectively, pumping the broccoli into a sterile fermentation tank by a thick slurry pump, adding 600 parts of red date extraction concentrated solution (containing adenosine cyclophosphate), 300 parts of ginseng extraction concentrated solution (containing ATP) and water, stirring and mixing uniformly, wherein in the step one, 300 parts of broccoli, 300 parts of red date extraction concentrated solution (containing adenosine cyclophosphate), 300 parts of ginseng extraction concentrated solution (containing ATP) and 500 parts of water are mixed.
Step two: performing enzymolysis before fermentation, namely adding pectinase and cellulase into the mixed pulp obtained by the pretreatment in the first step for enzymolysis, wherein the enzymolysis temperature is 40-55 ℃, the enzymolysis pH is 3.4-6.5, and the enzymolysis time is 2-8 h, the enzymolysis temperature in the second step is most preferably 48-52 ℃, the enzymolysis pH in the second step is most preferably 4.0-5.0, the enzymolysis time in the second step is preferably 4-5h, and the addition amount of the pectinase in the second step is 0.01-0.07%; wherein the addition amount of cellulase (1 wu/g) is 0.05-0.15%, the addition amount of pectinase in the second step is preferably 0.03-0.05%, and the addition amount of cellulase (1 wu/g) in the second step is preferably 0.1-0.12%.
Step three: fermenting, adding glucose, nicotinamide, magnesium sulfate and dipotassium hydrogen phosphate into the mixed solution obtained by the second enzymolysis, stirring for dissolving, heating, inactivating enzyme and sterilizing, cooling the mixed solution to 20-32 ℃, inoculating a leavening agent saccharomyces cerevisiae with the inoculum size of 0.05-0.1%, maintaining the temperature at 20-32 ℃, fermenting for 3-7 days, intermittently stirring in the fermentation process, stirring for 20-30 minutes every 12 hours, wherein the stirring mode can be mechanical stirring or stirring by introducing sterile compressed air, the fermentation strain obtained by separating and screening the fresh broccoli is used as an original strain, and is subjected to activation (slant culture), expanding culture (liquid culture) and Karschner jar amplification culture, fermentation broth is subjected to centrifugal separation after fermentation is finished to obtain saccharomyces cerevisiae bacterial sludge, and the saccharomyces cerevisiae bacterial sludge is inoculated to the broccoli enzymolysis mixed liquor for fermentation; or directly adding yeast liquid in a Kaschin tank into the blue flower enzymolysis mixed liquid for fermentation without centrifugal separation, wherein in the step three, the glucose is 1-8%, the nicotinamide is 0.1-1.0%, the magnesium sulfate is 0.01-0.03%, and the dipotassium hydrogen phosphate is 0.2-0.3%, wherein the enzyme inactivation and sterilization temperature is controlled at 60-90 ℃, preferably 75-85 ℃, and the enzyme inactivation and sterilization time is 10-40 minutes, preferably 20-30 minutes.
Step four: performing post-treatment, namely sterilizing, cooling, performing centrifugal separation on the fermentation liquor obtained in the third step to collect filtrate, concentrating the filtrate at low temperature under reduced pressure until the relative density of the extract is 1.01-1.05, and performing vacuum freeze drying to obtain the high-NMN-content broccoli extract, wherein the NMN content can reach more than 5.0% (w/w), and the extract can be used for anti-aging functional food; wherein the sterilization temperature is controlled at 60-90 deg.C, preferably 75-85 deg.C, and the sterilization time is 10-40 min, preferably 20-30 min; wherein the concentration temperature is 30-50 deg.C, preferably 35-45 deg.C, and vacuum degree is below 80 pa.
In the invention, the fermentation strain saccharomyces cerevisiae is obtained by separating and screening fresh broccoli and is used as an original strain to be prepared into a glycerol freezing pipe for preservation at (-80 ℃). And performing slant culture activation (culture medium: 2% of glucose, 1% of peptone, 1% of yeast extract powder, 1.5% of agar powder, 28 +/-2 ℃ and 42 hours) and liquid culture expansion culture (culture medium: 2% of glucose, 1% of peptone, 1% of yeast extract powder, 1.5% of agar powder, 250ml shaking table vibration, 28 +/-2 ℃ and 24 hours), inoculating the culture solution into a 10-liter Karschner jar filled with 5kg of wort (12 ℃) for amplification culture (25 ℃ and 72 hours), and after the fermentation is finished, centrifuging the fermentation liquor by a refrigerated centrifuge (4000 rpm and 10 minutes) to separate 120g of saccharomyces cerevisiae bacterial sludge (water content: 80%).
In the invention, the content determination method of the broccoli extract NMN comprises the following steps of: weighing the obtained stigma croci Sativi extract about 0.1g, precisely weighing, adding into 100ml volumetric flask, adding water 50ml for dissolving, ultrasonic treating for 10min, adding water for diluting to 100ml, and mixing. Putting part of the solution into a centrifuge tube, centrifuging at 4500r/min for 20min, collecting supernatant, and filtering with 0.45 μm filter membrane. And precisely weighing an appropriate amount of NMN reference substance to prepare a reference substance solution containing about 0.1mg/ml of NMN for later use.
In the invention, the chromatographic conditions of the high performance liquid chromatography are as follows: shimadzu Shim-packVP-ODS (150 mm. times.4.6 mm, 5 μm) column temperature: 40 ℃; mobile phase: a is 0.1% acetic acid water solution, B is methanol solution containing 2mmol/L ammonium acetate; flow rate 1.0mL/min, detection wavelength: 244nm, and the sample size is 10 μ L.
In the present invention, the gradient elution conditions are as follows:
| time (minutes) | Mobile phase A | |
| 0 | 95 | 5 |
| 3 | 65 | 35 |
| 5 | 0 | 100 |
| 8.1 | 95 | 5 |
| 12 | 95 | 5 |
。
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (10)
1. A preparation method of broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) is characterized by comprising the following steps:
the method comprises the following steps: pre-treating, selecting, cleaning, sterilizing with ozone, leaching, pulping, adding into sterile fermentation tank with thick pulp pump, adding concentrated extractive solution of fructus Jujubae (containing adenosine cyclophosphate), concentrated extractive solution of Ginseng radix (containing ATP), and water, stirring, and mixing.
Step two: and (3) performing enzymolysis before fermentation, namely adding pectinase and cellulase into the mixed pulp obtained by the pretreatment in the step one to perform enzymolysis, wherein the enzymolysis temperature is 40-55 ℃, the enzymolysis pH is 3.4-6.5, and the enzymolysis time is 2-8 h.
Step three: and (3) fermenting, namely adding glucose, nicotinamide, magnesium sulfate and dipotassium hydrogen phosphate into the mixed liquor obtained in the second enzymolysis step respectively, stirring for dissolving, heating, carrying out enzyme deactivation and sterilization, cooling the mixed liquor to 20-32 ℃, inoculating a starter saccharomyces cerevisiae with the inoculation amount of 0.05-0.1%, maintaining the temperature at 20-32 ℃, fermenting for 3-7 days, intermittently stirring in the fermentation process, stirring for 20-30 minutes every 12 hours, wherein the stirring mode can be mechanical stirring, and can also be stirring by introducing sterile compressed air.
Step four: performing post-treatment, namely sterilizing, cooling, performing centrifugal separation on the fermentation liquor obtained in the third step to collect filtrate, concentrating the filtrate at low temperature under reduced pressure until the relative density of the extract is 1.01-1.05, and performing vacuum freeze drying to obtain the high-NMN-content broccoli extract, wherein the NMN content can reach more than 5.0% (w/w), and the extract can be used for anti-aging functional food; wherein the sterilization temperature is controlled at 60-90 deg.C, preferably 75-85 deg.C, and the sterilization time is 10-40 min, preferably 20-30 min; wherein the concentration temperature is 30-50 deg.C, preferably 35-45 deg.C, and vacuum degree is below 80 pa.
2. The method as claimed in claim 1, wherein the extract of Siberian blue flower with high content of β -Nicotinamide Mononucleotide (NMN) comprises 600 parts of Siberian blue flower, 300 parts of concentrated extract of red date (containing adenosine cyclophosphate), 300 parts of concentrated extract of ginseng (containing ATP) and 500 parts of water.
3. The method for preparing the broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to claim 1, wherein the enzymolysis temperature in the second step is most preferably 48-52 ℃.
4. The method for preparing broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to claim 1, wherein the enzymolysis in the second step is performed at pH 4.0-5.0.
5. The method for preparing broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to claim 1, wherein the enzymolysis time in the second step is preferably 4-5 h.
6. The method for preparing broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to claim 1, wherein the amount of pectinase added in step two is 0.01-0.07%; wherein the addition amount of cellulase (1 ten thousand u/g) is 0.05-0.15%.
7. The method for preparing broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to claim 6, wherein the addition amount of pectinase in the second step is preferably 0.03% -0.05%.
8. The method for preparing broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to claim 6, wherein the cellulase (1 wu/g) is added in the second step preferably in an amount of 0.1-0.12%.
9. The method for preparing the broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to claim 1, wherein the fermentation strain obtained in the third step is obtained by separating and screening fresh broccoli, is used as an original strain, and is subjected to activation (slant culture), amplification culture (liquid culture) and amplification culture in a Karschner jar, fermentation broth is subjected to centrifugal separation after fermentation is finished to obtain saccharomyces cerevisiae bacterial sludge, and is inoculated to the broccoli enzymolysis mixed liquor for fermentation; or directly adding the yeast liquid in the Kaschin tank into the blue flower enzymolysis mixed liquid for fermentation without centrifugal separation.
10. The preparation method of broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) according to claim 1, wherein glucose is 1-8%, nicotinamide is 0.1-1.0%, magnesium sulfate is 0.01-0.03%, dipotassium hydrogen phosphate is 0.2-0.3%, enzyme inactivation and sterilization temperature is controlled at 60-90 ℃, preferably 75-85 ℃, and enzyme inactivation and sterilization time is 10-40 minutes, preferably 20-30 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110229958.8A CN112869164B (en) | 2021-03-02 | 2021-03-02 | Preparation method of broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110229958.8A CN112869164B (en) | 2021-03-02 | 2021-03-02 | Preparation method of broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112869164A true CN112869164A (en) | 2021-06-01 |
| CN112869164B CN112869164B (en) | 2023-04-07 |
Family
ID=76055267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110229958.8A Active CN112869164B (en) | 2021-03-02 | 2021-03-02 | Preparation method of broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112869164B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113845986A (en) * | 2021-10-29 | 2021-12-28 | 上海舒泽生物科技研究所 | Health wine, preparation method and use method thereof |
| CN114835768A (en) * | 2022-05-19 | 2022-08-02 | 浙江省农业科学院 | Method for extracting beta-nicotinamide mononucleotide from fruits and vegetables and purification method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018120069A1 (en) * | 2016-12-29 | 2018-07-05 | 苏州汉酶生物技术有限公司 | METHOD FOR ENZYMATICALLY PREPARING β-NICOTINAMIDE MONONUCLEOTIDE |
| CN110559224A (en) * | 2019-08-30 | 2019-12-13 | 广东丸美生物技术股份有限公司 | Broccoli extract and preparation method and application thereof |
| CN111548382A (en) * | 2020-05-29 | 2020-08-18 | 广州颜如玉生物科技有限公司 | Method for extracting nicotinamide mononucleotide from avocado |
-
2021
- 2021-03-02 CN CN202110229958.8A patent/CN112869164B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018120069A1 (en) * | 2016-12-29 | 2018-07-05 | 苏州汉酶生物技术有限公司 | METHOD FOR ENZYMATICALLY PREPARING β-NICOTINAMIDE MONONUCLEOTIDE |
| CN110559224A (en) * | 2019-08-30 | 2019-12-13 | 广东丸美生物技术股份有限公司 | Broccoli extract and preparation method and application thereof |
| CN111548382A (en) * | 2020-05-29 | 2020-08-18 | 广州颜如玉生物科技有限公司 | Method for extracting nicotinamide mononucleotide from avocado |
Non-Patent Citations (1)
| Title |
|---|
| 史海波等: "β-烟酰胺单核苷酸制备研究进展", 《精细化工中间体》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113845986A (en) * | 2021-10-29 | 2021-12-28 | 上海舒泽生物科技研究所 | Health wine, preparation method and use method thereof |
| CN114835768A (en) * | 2022-05-19 | 2022-08-02 | 浙江省农业科学院 | Method for extracting beta-nicotinamide mononucleotide from fruits and vegetables and purification method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112869164B (en) | 2023-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112869164B (en) | Preparation method of broccoli extract with high content of beta-Nicotinamide Mononucleotide (NMN) | |
| CN107868805B (en) | Longan polysaccharide degraded by lactobacillus fermentation and preparation method thereof | |
| WO2015103974A1 (en) | Method for extracting and purifying l-ergothioneine | |
| CN101492706A (en) | Method for improving cordyceps sinensis bacterium native volume of production with cordyceps militaris link liquid fermentation | |
| CN105647814A (en) | Rapid liquid submerged fermentation method for producing paecilomyces cicadae powder | |
| CN109504725B (en) | Method for preparing high-purity hericium erinaceus polysaccharide by fermenting hericium erinaceus and fermentation culture medium | |
| CN106086147A (en) | Fungal elicitor is utilized to induce the method extracting betulic acid from Inonqqus obliquus | |
| CN113321580B (en) | Method for producing malic acid | |
| CN112890167B (en) | Ganoderma lucidum spore powder and agaricus blazei murill capsule and preparation method thereof | |
| CN111607622B (en) | Process method for producing 3-hydroxy butanone by using wheat B starch | |
| CN103554287B (en) | A kind of extracting method of King Boletus mycelia polysaccharide | |
| CN110106219B (en) | Method for recycling residue of cordyceps militaris solid culture medium | |
| CN101215590B (en) | Method for removing monosaccharide component from oligomerization galactose by utilizing immobilized yeast | |
| CN109673393A (en) | A kind of production method of peacilomyce hepiahi bacterium filament | |
| CN105200102B (en) | The method of glutathione is extracted from candida utili fermentation liquid | |
| CN114181842B (en) | Saccharomycopsis fibuligera cx-3 strain for converting anthocyanin to produce protocatechuic acid and application thereof | |
| CN115261414A (en) | Method for preparing tremella fermentation liquor by combining compound enzyme with microbial fermentation | |
| CN105087427B (en) | Produce Vibrio natriegen and its application of agarase | |
| JPS60244294A (en) | Process for semicontinuous production of alcohol in high concentration from cellulose | |
| CN104705764A (en) | Solid-liquid separation method for fermentation product | |
| CN104357339A (en) | Strain for producing xylitol and method for producing xylitol | |
| CN111549083B (en) | Application of trichoderma pleuroticola ZJ-03 in deep processing of industrial hemp | |
| CN109247580B (en) | Application of cordyceps sinensis extracellular polysaccharide in probiotic health food and/or probiotic traditional Chinese medicine | |
| CN107384986A (en) | A kind of method that tea polysaccharide is extracted using biotechnology | |
| AU2020102037A4 (en) | A method of efficiently increasing the alpha-glucosidase inhibitor content in fresh mulberry leaves by the solid-state fermentation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |